anti-obesity anti-obesity
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 18-45 years, BMI 27-35 kg/m2 (inclusive)
Exclusion criteria
Exclusion criteria: Suffering from: hepatitis B, cancer or HIV/Aids. In case of participation in another drug study within 60 days before the start of this study or being a blood donor within 60 days from the start of the study. In case of donating more than 1.5 liters blood in the 10 months preceding the start of the study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To evaluate the logistics, feasibility, and safety of procedures for a clinical trial that will assess methodologies used to evaluate ketogenesis and glucose-dependent insulin secretion. | — |
Countries
Netherlands